Stryker Agrees to Pay at Least $1 Billion to Settle Recalled Rejuvenate and ABG II Modular Hips

Share Article

Settlement reached in Stryker Rejuvenate and ABG II hip implant litigation with Kelley, Bernheim & Dolinsky, LLC at the forefront of national and state court proceedings.

“After years of hard work, this settlement announcement is a positive development in holding Stryker fully accountable for their actions.” -Jesse Bernheim, MDL & Broward County Liaison Counsel

On Monday, a global settlement was announced between Stryker Corp. and thousands of Plaintiffs nationwide who were previously implanted with the company’s recalled Rejuvenate and ABG II modular hip implants. The total amount paid out by Stryker is expected to exceed $1 billion for complications resulting from these hip systems.

Stryker Corp. will pay a base amount of $300,000 per case to patients who had the recalled device removed on or before November 2, 2014, or who otherwise qualify under the terms of the settlement proposal. Throughout the coming months, each plaintiff’s claim will be evaluated on a case-by-case basis. Claimants interested in applying for the program must do so by March 2, 2015.

The settlement program was announced in the multi-district litigation (MDL) consolidated in federal court in the District of Minnesota and suits filed in New Jersey state court’s Multi-county Litigation (MCL). Approximately 1,800 cases have been consolidated in United States District Court for the District of Minnesota (In Re Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, 13-MDL-2441) and over 2,100 cases are pending in New Jersey state court (In Re Stryker Rejuvenate and ABG II Modular Hip Implant Litigation, Case No. 296 BER-L-936-13, Bergen County Superior Court).

Attorney Jesse Bernheim, founding partner of Kelley, Bernheim & Dolinsky LLC, is federally-appointed Liaison counsel to the MDL as well as Liaison Counsel in Broward County’s consolidated litigation. “After years of hard work, this settlement announcement is a positive development in holding Stryker fully accountable for their actions,” said Bernheim in a statement made following the announcement of Stryker's mass settlement.

In July of 2012, Stryker recalled the Rejuvenate and ABG II modular hip systems because of failure related to fretting and corrosion of the stem which caused pain, dislocation, adverse local tissue reaction, pseudo tumor, tissue and bone death, increased metal ions in the bloodstream (metallosis), infection, and revision surgery to have the implants removed.

Kelley, Bernheim, & Dolinksy, LLC is on the forefront of this litigation and was the first to file lawsuits in several states. For years the firm has worked to prosecute Stryker for putting these defective devices on the market. Contact one of the medical product liability lawyers at Kelley, Bernheim & Dolinsky today for a free consultation.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Gallant, Esq.

Jesse Bernheim, Esq.